id	sid	tid	token	lemma	pos
ffhd-1605	1	1	safety	safety	NOUN
ffhd-1605	1	2	and	and	CCONJ
ffhd-1605	1	3	efficacy	efficacy	NOUN
ffhd-1605	1	4	study	study	NOUN
ffhd-1605	1	5	of	of	ADP
ffhd-1605	1	6	lutein	lutein	PROPN
ffhd-1605	1	7	(	(	PUNCT
ffhd-1605	1	8	vitalutein	vitalutein	PROPN
ffhd-1605	1	9	®	®	PROPN
ffhd-1605	1	10	)	)	PUNCT
ffhd-1605	1	11	in	in	ADP
ffhd-1605	1	12	healthy	healthy	ADJ
ffhd-1605	1	13	japanese	japanese	ADJ
ffhd-1605	1	14	adults	adult	NOUN
ffhd-1605	1	15	:	:	PUNCT
ffhd-1605	1	16	a	a	DET
ffhd-1605	1	17	randomized	randomized	ADJ
ffhd-1605	1	18	,	,	PUNCT
ffhd-1605	1	19	placebo	placebo	NOUN
ffhd-1605	1	20	-	-	PUNCT
ffhd-1605	1	21	controlled	control	VERB
ffhd-1605	1	22	,	,	PUNCT
ffhd-1605	1	23	double	double	ADJ
ffhd-1605	1	24	-	-	PUNCT
ffhd-1605	1	25	blind	blind	ADJ
ffhd-1605	1	26	,	,	PUNCT
ffhd-1605	1	27	parallel	parallel	ADJ
ffhd-1605	1	28	-	-	PUNCT
ffhd-1605	1	29	group	group	NOUN
ffhd-1605	1	30	comparative	comparative	ADJ
ffhd-1605	1	31	study	study	NOUN
ffhd-1605	1	32	|	|	ADP
ffhd-1605	1	33	functional	functional	ADJ
ffhd-1605	1	34	foods	food	NOUN
ffhd-1605	1	35	in	in	ADP
ffhd-1605	1	36	health	health	NOUN
ffhd-1605	1	37	and	and	CCONJ
ffhd-1605	1	38	disease	disease	PROPN
ffhd-1605	1	39	online	online	PROPN
ffhd-1605	1	40	issn	issn	PROPN
ffhd-1605	1	41	:	:	PUNCT
ffhd-1605	1	42	2160	2160	NUM
ffhd-1605	1	43	-	-	SYM
ffhd-1605	1	44	3855	3855	NUM
ffhd-1605	1	45	;	;	PUNCT
ffhd-1605	1	46	print	print	NOUN
ffhd-1605	1	47	issn	issn	PROPN
ffhd-1605	1	48	:	:	PUNCT
ffhd-1605	1	49	2378	2378	NUM
ffhd-1605	1	50	-	-	SYM
ffhd-1605	1	51	7007	7007	NUM
ffhd-1605	1	52	skip	skip	NOUN
ffhd-1605	1	53	to	to	ADP
ffhd-1605	1	54	main	main	ADJ
ffhd-1605	1	55	content	content	NOUN
ffhd-1605	1	56	skip	skip	ADJ
ffhd-1605	1	57	to	to	ADP
ffhd-1605	1	58	main	main	ADJ
ffhd-1605	1	59	navigation	navigation	NOUN
ffhd-1605	1	60	menu	menu	NOUN
ffhd-1605	1	61	skip	skip	VERB
ffhd-1605	1	62	to	to	PART
ffhd-1605	1	63	site	site	VERB
ffhd-1605	1	64	footer	footer	ADJ
ffhd-1605	1	65	open	open	ADJ
ffhd-1605	1	66	menu	menu	NOUN
ffhd-1605	1	67	functional	functional	ADJ
ffhd-1605	1	68	foods	food	NOUN
ffhd-1605	1	69	in	in	ADP
ffhd-1605	1	70	health	health	NOUN
ffhd-1605	1	71	and	and	CCONJ
ffhd-1605	1	72	disease	disease	PROPN
ffhd-1605	1	73	online	online	PROPN
ffhd-1605	1	74	issn	issn	PROPN
ffhd-1605	1	75	:	:	PUNCT
ffhd-1605	1	76	2160	2160	NUM
ffhd-1605	1	77	-	-	SYM
ffhd-1605	1	78	3855	3855	NUM
ffhd-1605	1	79	;	;	PUNCT
ffhd-1605	1	80	print	print	NOUN
ffhd-1605	1	81	issn	issn	PROPN
ffhd-1605	1	82	:	:	PUNCT
ffhd-1605	1	83	2378	2378	NUM
ffhd-1605	1	84	-	-	SYM
ffhd-1605	1	85	7007	7007	NUM
ffhd-1605	1	86	home	home	NOUN
ffhd-1605	1	87	food	food	NOUN
ffhd-1605	1	88	science	science	NOUN
ffhd-1605	1	89	publisher	publisher	NOUN
ffhd-1605	1	90	functional	functional	ADJ
ffhd-1605	1	91	food	food	NOUN
ffhd-1605	1	92	center	center	NOUN
ffhd-1605	1	93	current	current	ADJ
ffhd-1605	1	94	archives	archive	NOUN
ffhd-1605	1	95	about	about	ADP
ffhd-1605	1	96	about	about	ADP
ffhd-1605	1	97	the	the	DET
ffhd-1605	1	98	journal	journal	NOUN
ffhd-1605	1	99	aims	aim	VERB
ffhd-1605	1	100	and	and	CCONJ
ffhd-1605	1	101	scope	scope	NOUN
ffhd-1605	1	102	contact	contact	NOUN
ffhd-1605	1	103	editing	edit	VERB
ffhd-1605	1	104	services	service	NOUN
ffhd-1605	1	105	editorial	editorial	ADJ
ffhd-1605	1	106	team	team	NOUN
ffhd-1605	1	107	express	express	VERB
ffhd-1605	1	108	peer	peer	NOUN
ffhd-1605	1	109	review	review	NOUN
ffhd-1605	1	110	graphical	graphical	ADJ
ffhd-1605	1	111	abstract	abstract	ADJ
ffhd-1605	1	112	journal	journal	NOUN
ffhd-1605	1	113	insights	insight	VERB
ffhd-1605	1	114	privacy	privacy	NOUN
ffhd-1605	1	115	statement	statement	NOUN
ffhd-1605	1	116	submissions	submission	NOUN
ffhd-1605	1	117	announcements	announcement	NOUN
ffhd-1605	1	118	search	search	NOUN
ffhd-1605	1	119	search	search	NOUN
ffhd-1605	1	120	register	register	NOUN
ffhd-1605	1	121	login	login	NOUN
ffhd-1605	1	122	home	home	NOUN
ffhd-1605	1	123	/	/	SYM
ffhd-1605	1	124	archives	archive	NOUN
ffhd-1605	1	125	/	/	SYM
ffhd-1605	1	126	vol	vol	NOUN
ffhd-1605	1	127	.	.	PROPN
ffhd-1605	1	128	15	15	NUM
ffhd-1605	2	1	no	no	NOUN
ffhd-1605	2	2	.	.	NOUN
ffhd-1605	2	3	5	5	NUM
ffhd-1605	2	4	(	(	PUNCT
ffhd-1605	2	5	2025	2025	NUM
ffhd-1605	2	6	):	):	PUNCT
ffhd-1605	2	7	may	may	PROPN
ffhd-1605	2	8	2025	2025	NUM
ffhd-1605	2	9	/	/	SYM
ffhd-1605	2	10	research	research	NOUN
ffhd-1605	2	11	articles	article	NOUN
ffhd-1605	2	12	safety	safety	NOUN
ffhd-1605	2	13	and	and	CCONJ
ffhd-1605	2	14	efficacy	efficacy	NOUN
ffhd-1605	2	15	study	study	NOUN
ffhd-1605	2	16	of	of	ADP
ffhd-1605	2	17	lutein	lutein	PROPN
ffhd-1605	2	18	(	(	PUNCT
ffhd-1605	2	19	vitalutein	vitalutein	PROPN
ffhd-1605	2	20	®	®	PROPN
ffhd-1605	2	21	)	)	PUNCT
ffhd-1605	2	22	in	in	ADP
ffhd-1605	2	23	healthy	healthy	ADJ
ffhd-1605	2	24	japanese	japanese	ADJ
ffhd-1605	2	25	adults	adult	NOUN
ffhd-1605	2	26	:	:	PUNCT
ffhd-1605	2	27	a	a	PRON
ffhd-1605	2	28	randomized	randomized	ADJ
ffhd-1605	2	29	,	,	PUNCT
ffhd-1605	2	30	placebo	placebo	NOUN
ffhd-1605	2	31	-	-	PUNCT
ffhd-1605	2	32	controlled	control	VERB
ffhd-1605	2	33	,	,	PUNCT
ffhd-1605	2	34	double	double	ADJ
ffhd-1605	2	35	-	-	PUNCT
ffhd-1605	2	36	blind	blind	ADJ
ffhd-1605	2	37	,	,	PUNCT
ffhd-1605	2	38	parallel	parallel	ADJ
ffhd-1605	2	39	-	-	PUNCT
ffhd-1605	2	40	group	group	NOUN
ffhd-1605	2	41	comparative	comparative	ADJ
ffhd-1605	2	42	study	study	NOUN
ffhd-1605	2	43	authors	author	NOUN
ffhd-1605	2	44	hyunjin	hyunjin	VERB
ffhd-1605	2	45	lee	lee	PROPN
ffhd-1605	2	46	takayuki	takayuki	PROPN
ffhd-1605	2	47	itano	itano	PROPN
ffhd-1605	2	48	faizal	faizal	PROPN
ffhd-1605	2	49	mohamed	mohamed	PROPN
ffhd-1605	2	50	naoko	naoko	PROPN
ffhd-1605	2	51	suzuki	suzuki	PROPN
ffhd-1605	2	52	tsuyoshi	tsuyoshi	PROPN
ffhd-1605	2	53	takara	takara	PROPN
ffhd-1605	2	54	takahiro	takahiro	PROPN
ffhd-1605	2	55	yamada	yamada	PROPN
ffhd-1605	2	56	doi	doi	PROPN
ffhd-1605	2	57	:	:	PUNCT
ffhd-1605	2	58	https://doi.org/10.31989/ffhd.v15i5.1605	https://doi.org/10.31989/ffhd.v15i5.1605	X
ffhd-1605	2	59	abstract	abstract	ADJ
ffhd-1605	2	60	background	background	NOUN
ffhd-1605	2	61	:	:	PUNCT
ffhd-1605	2	62	lutein	lutein	PROPN
ffhd-1605	2	63	is	be	AUX
ffhd-1605	2	64	a	a	DET
ffhd-1605	2	65	natural	natural	ADJ
ffhd-1605	2	66	pigment	pigment	NOUN
ffhd-1605	2	67	with	with	ADP
ffhd-1605	2	68	antioxidant	antioxidant	ADJ
ffhd-1605	2	69	properties	property	NOUN
ffhd-1605	2	70	found	find	VERB
ffhd-1605	2	71	in	in	ADP
ffhd-1605	2	72	both	both	CCONJ
ffhd-1605	2	73	the	the	DET
ffhd-1605	2	74	eye	eye	NOUN
ffhd-1605	2	75	's	's	PART
ffhd-1605	2	76	lens	lens	NOUN
ffhd-1605	2	77	and	and	CCONJ
ffhd-1605	2	78	macula	macula	NOUN
ffhd-1605	2	79	.	.	PUNCT
ffhd-1605	3	1	daily	daily	ADJ
ffhd-1605	3	2	exposure	exposure	NOUN
ffhd-1605	3	3	to	to	ADP
ffhd-1605	3	4	certain	certain	ADJ
ffhd-1605	3	5	wavelengths	wavelength	NOUN
ffhd-1605	3	6	of	of	ADP
ffhd-1605	3	7	light	light	ADJ
ffhd-1605	3	8	-particularly	-particularly	ADV
ffhd-1605	3	9	blue	blue	ADJ
ffhd-1605	3	10	and	and	CCONJ
ffhd-1605	3	11	infrared	infrared	ADJ
ffhd-1605	3	12	–	–	PUNCT
ffhd-1605	3	13	can	can	AUX
ffhd-1605	3	14	increase	increase	VERB
ffhd-1605	3	15	the	the	DET
ffhd-1605	3	16	eyes	eye	NOUN
ffhd-1605	3	17	'	'	PART
ffhd-1605	3	18	vulnerability	vulnerability	NOUN
ffhd-1605	3	19	to	to	PART
ffhd-1605	3	20	oxidative	oxidative	ADJ
ffhd-1605	3	21	damage	damage	NOUN
ffhd-1605	3	22	caused	cause	VERB
ffhd-1605	3	23	by	by	ADP
ffhd-1605	3	24	free	free	ADJ
ffhd-1605	3	25	radicals	radical	NOUN
ffhd-1605	3	26	.	.	PUNCT
ffhd-1605	4	1	however	however	ADV
ffhd-1605	4	2	,	,	PUNCT
ffhd-1605	4	3	lutein	lutein	PROPN
ffhd-1605	4	4	’s	’s	PART
ffhd-1605	4	5	antioxidant	antioxidant	ADJ
ffhd-1605	4	6	properties	property	NOUN
ffhd-1605	4	7	help	help	VERB
ffhd-1605	4	8	protect	protect	VERB
ffhd-1605	4	9	cells	cell	NOUN
ffhd-1605	4	10	from	from	ADP
ffhd-1605	4	11	oxidative	oxidative	ADJ
ffhd-1605	4	12	damage	damage	NOUN
ffhd-1605	4	13	.	.	PUNCT
ffhd-1605	4	14	  	  	SPACE
ffhd-1605	5	1	objective	objective	NOUN
ffhd-1605	5	2	:	:	PUNCT
ffhd-1605	5	3	this	this	DET
ffhd-1605	5	4	study	study	NOUN
ffhd-1605	5	5	aimed	aim	VERB
ffhd-1605	5	6	to	to	PART
ffhd-1605	5	7	evaluate	evaluate	VERB
ffhd-1605	5	8	the	the	DET
ffhd-1605	5	9	reduction	reduction	NOUN
ffhd-1605	5	10	of	of	ADP
ffhd-1605	5	11	oxidative	oxidative	ADJ
ffhd-1605	5	12	stress	stress	NOUN
ffhd-1605	5	13	in	in	ADP
ffhd-1605	5	14	tears	tear	NOUN
ffhd-1605	5	15	resulting	result	VERB
ffhd-1605	5	16	from	from	ADP
ffhd-1605	5	17	daily	daily	ADJ
ffhd-1605	5	18	intake	intake	NOUN
ffhd-1605	5	19	of	of	ADP
ffhd-1605	5	20	vitalutein	vitalutein	PROPN
ffhd-1605	5	21	®	®	PROPN
ffhd-1605	5	22	,	,	PUNCT
ffhd-1605	5	23	within	within	ADP
ffhd-1605	5	24	healthy	healthy	ADJ
ffhd-1605	5	25	japanese	japanese	ADJ
ffhd-1605	5	26	adults	adult	NOUN
ffhd-1605	5	27	.	.	PUNCT
ffhd-1605	6	1	the	the	DET
ffhd-1605	6	2	safety	safety	NOUN
ffhd-1605	6	3	of	of	ADP
ffhd-1605	6	4	oral	oral	ADJ
ffhd-1605	6	5	vitalutein	vitalutein	NOUN
ffhd-1605	6	6	®	®	NOUN
ffhd-1605	6	7	intake	intake	NOUN
ffhd-1605	6	8	was	be	AUX
ffhd-1605	6	9	also	also	ADV
ffhd-1605	6	10	assessed	assess	VERB
ffhd-1605	6	11	.	.	PUNCT
ffhd-1605	7	1	methods	method	NOUN
ffhd-1605	7	2	:	:	PUNCT
ffhd-1605	7	3	a	a	DET
ffhd-1605	7	4	randomized	randomized	ADJ
ffhd-1605	7	5	,	,	PUNCT
ffhd-1605	7	6	placebo	placebo	NOUN
ffhd-1605	7	7	-	-	PUNCT
ffhd-1605	7	8	controlled	control	VERB
ffhd-1605	7	9	,	,	PUNCT
ffhd-1605	7	10	double	double	ADJ
ffhd-1605	7	11	-	-	PUNCT
ffhd-1605	7	12	blind	blind	ADJ
ffhd-1605	7	13	,	,	PUNCT
ffhd-1605	7	14	parallel	parallel	ADJ
ffhd-1605	7	15	-	-	PUNCT
ffhd-1605	7	16	group	group	NOUN
ffhd-1605	7	17	study	study	NOUN
ffhd-1605	7	18	was	be	AUX
ffhd-1605	7	19	conducted	conduct	VERB
ffhd-1605	7	20	.	.	PUNCT
ffhd-1605	8	1	thirty	thirty	NUM
ffhd-1605	8	2	-	-	PUNCT
ffhd-1605	8	3	one	one	NUM
ffhd-1605	8	4	healthy	healthy	ADJ
ffhd-1605	8	5	japanese	japanese	ADJ
ffhd-1605	8	6	adults	adult	NOUN
ffhd-1605	8	7	were	be	AUX
ffhd-1605	8	8	randomized	randomize	VERB
ffhd-1605	8	9	to	to	ADP
ffhd-1605	8	10	either	either	CCONJ
ffhd-1605	8	11	the	the	DET
ffhd-1605	8	12	placebo	placebo	NOUN
ffhd-1605	8	13	or	or	CCONJ
ffhd-1605	8	14	vitalutein	vitalutein	NOUN
ffhd-1605	8	15	®	®	NOUN
ffhd-1605	8	16	group	group	NOUN
ffhd-1605	8	17	.	.	PUNCT
ffhd-1605	9	1	participants	participant	NOUN
ffhd-1605	9	2	were	be	AUX
ffhd-1605	9	3	enrolled	enrol	VERB
ffhd-1605	9	4	based	base	VERB
ffhd-1605	9	5	on	on	ADP
ffhd-1605	9	6	levels	level	NOUN
ffhd-1605	9	7	of	of	ADP
ffhd-1605	9	8	8	8	NUM
ffhd-1605	9	9	-	-	PUNCT
ffhd-1605	9	10	hydroxydeoxyguanosine	hydroxydeoxyguanosine	NOUN
ffhd-1605	9	11	(	(	PUNCT
ffhd-1605	9	12	8	8	NUM
ffhd-1605	9	13	-	-	NUM
ffhd-1605	9	14	ohdg	ohdg	NUM
ffhd-1605	9	15	)	)	PUNCT
ffhd-1605	9	16	in	in	ADP
ffhd-1605	9	17	their	their	PRON
ffhd-1605	9	18	tears	tear	NOUN
ffhd-1605	9	19	.	.	PUNCT
ffhd-1605	10	1	fifteen	fifteen	NUM
ffhd-1605	10	2	adults	adult	NOUN
ffhd-1605	10	3	were	be	AUX
ffhd-1605	10	4	assigned	assign	VERB
ffhd-1605	10	5	to	to	ADP
ffhd-1605	10	6	the	the	DET
ffhd-1605	10	7	vitalutein	vitalutein	NOUN
ffhd-1605	10	8	®	®	NOUN
ffhd-1605	10	9	group	group	NOUN
ffhd-1605	10	10	and	and	CCONJ
ffhd-1605	10	11	sixteen	sixteen	NUM
ffhd-1605	10	12	to	to	ADP
ffhd-1605	10	13	the	the	DET
ffhd-1605	10	14	placebo	placebo	NOUN
ffhd-1605	10	15	group	group	NOUN
ffhd-1605	10	16	.	.	PUNCT
ffhd-1605	11	1	after	after	ADP
ffhd-1605	11	2	8	8	NUM
ffhd-1605	11	3	-	-	PUNCT
ffhd-1605	11	4	weeks	week	NOUN
ffhd-1605	11	5	,	,	PUNCT
ffhd-1605	11	6	all	all	DET
ffhd-1605	11	7	subjects	subject	NOUN
ffhd-1605	11	8	were	be	AUX
ffhd-1605	11	9	evaluated	evaluate	VERB
ffhd-1605	11	10	for	for	ADP
ffhd-1605	11	11	oxidative	oxidative	ADJ
ffhd-1605	11	12	stress	stress	NOUN
ffhd-1605	11	13	,	,	PUNCT
ffhd-1605	11	14	macular	macular	ADJ
ffhd-1605	11	15	pigment	pigment	ADJ
ffhd-1605	11	16	optical	optical	ADJ
ffhd-1605	11	17	density	density	NOUN
ffhd-1605	11	18	,	,	PUNCT
ffhd-1605	11	19	and	and	CCONJ
ffhd-1605	11	20	dry	dry	ADJ
ffhd-1605	11	21	eye	eye	NOUN
ffhd-1605	11	22	symptoms	symptom	NOUN
ffhd-1605	11	23	.	.	PUNCT
ffhd-1605	12	1	safety	safety	NOUN
ffhd-1605	12	2	assessments	assessment	NOUN
ffhd-1605	12	3	included	include	VERB
ffhd-1605	12	4	urinalysis	urinalysis	NOUN
ffhd-1605	12	5	and	and	CCONJ
ffhd-1605	12	6	blood	blood	NOUN
ffhd-1605	12	7	tests	test	NOUN
ffhd-1605	12	8	.	.	PUNCT
ffhd-1605	13	1	results	result	NOUN
ffhd-1605	13	2	:	:	PUNCT
ffhd-1605	13	3	no	no	DET
ffhd-1605	13	4	adverse	adverse	ADJ
ffhd-1605	13	5	events	event	NOUN
ffhd-1605	13	6	were	be	AUX
ffhd-1605	13	7	attributed	attribute	VERB
ffhd-1605	13	8	to	to	ADP
ffhd-1605	13	9	the	the	DET
ffhd-1605	13	10	test	test	NOUN
ffhd-1605	13	11	food	food	NOUN
ffhd-1605	13	12	during	during	ADP
ffhd-1605	13	13	the	the	DET
ffhd-1605	13	14	study	study	NOUN
ffhd-1605	13	15	period	period	NOUN
ffhd-1605	13	16	.	.	PUNCT
ffhd-1605	14	1	levels	level	NOUN
ffhd-1605	14	2	of	of	ADP
ffhd-1605	14	3	8	8	NUM
ffhd-1605	14	4	-	-	PUNCT
ffhd-1605	14	5	ohdg	ohdg	NOUN
ffhd-1605	14	6	were	be	AUX
ffhd-1605	14	7	significantly	significantly	ADV
ffhd-1605	14	8	reduced	reduce	VERB
ffhd-1605	14	9	at	at	ADP
ffhd-1605	14	10	week	week	NOUN
ffhd-1605	14	11	8	8	NUM
ffhd-1605	14	12	compared	compare	VERB
ffhd-1605	14	13	to	to	PART
ffhd-1605	14	14	baseline	baseline	VERB
ffhd-1605	14	15	in	in	ADP
ffhd-1605	14	16	the	the	DET
ffhd-1605	14	17	vitalutein	vitalutein	NOUN
ffhd-1605	14	18	®	®	NOUN
ffhd-1605	14	19	group	group	NOUN
ffhd-1605	14	20	.	.	PUNCT
ffhd-1605	15	1	additionally	additionally	ADV
ffhd-1605	15	2	,	,	PUNCT
ffhd-1605	15	3	participants	participant	NOUN
ffhd-1605	15	4	with	with	ADP
ffhd-1605	15	5	prolonged	prolonged	ADJ
ffhd-1605	15	6	visual	visual	ADJ
ffhd-1605	15	7	display	display	NOUN
ffhd-1605	15	8	terminal	terminal	PROPN
ffhd-1605	15	9	(	(	PUNCT
ffhd-1605	15	10	vdt	vdt	PROPN
ffhd-1605	15	11	)	)	PUNCT
ffhd-1605	15	12	use	use	NOUN
ffhd-1605	15	13	maintained	maintain	VERB
ffhd-1605	15	14	higher	high	ADJ
ffhd-1605	15	15	macular	macular	ADJ
ffhd-1605	15	16	pigment	pigment	ADJ
ffhd-1605	15	17	optical	optical	ADJ
ffhd-1605	15	18	density	density	NOUN
ffhd-1605	15	19	(	(	PUNCT
ffhd-1605	15	20	mpod	mpod	NOUN
ffhd-1605	15	21	)	)	PUNCT
ffhd-1605	15	22	levels	level	NOUN
ffhd-1605	15	23	compared	compare	VERB
ffhd-1605	15	24	to	to	ADP
ffhd-1605	15	25	the	the	DET
ffhd-1605	15	26	placebo	placebo	NOUN
ffhd-1605	15	27	group	group	NOUN
ffhd-1605	15	28	.	.	PUNCT
ffhd-1605	16	1	novelty	novelty	NOUN
ffhd-1605	16	2	:	:	PUNCT
ffhd-1605	17	1	this	this	PRON
ffhd-1605	17	2	randomized	randomize	VERB
ffhd-1605	17	3	controlled	control	VERB
ffhd-1605	17	4	trial	trial	NOUN
ffhd-1605	17	5	uniquely	uniquely	ADV
ffhd-1605	17	6	demonstrates	demonstrate	VERB
ffhd-1605	17	7	the	the	DET
ffhd-1605	17	8	safety	safety	NOUN
ffhd-1605	17	9	of	of	ADP
ffhd-1605	17	10	vitalutein	vitalutein	NOUN
ffhd-1605	17	11	®	®	NOUN
ffhd-1605	17	12	supplementation	supplementation	NOUN
ffhd-1605	17	13	in	in	ADP
ffhd-1605	17	14	healthy	healthy	ADJ
ffhd-1605	17	15	japanese	japanese	ADJ
ffhd-1605	17	16	adults	adult	NOUN
ffhd-1605	17	17	.	.	PUNCT
ffhd-1605	18	1	this	this	DET
ffhd-1605	18	2	study	study	NOUN
ffhd-1605	18	3	provides	provide	VERB
ffhd-1605	18	4	preliminary	preliminary	ADJ
ffhd-1605	18	5	evidence	evidence	NOUN
ffhd-1605	18	6	suggesting	suggest	VERB
ffhd-1605	18	7	its	its	PRON
ffhd-1605	18	8	potential	potential	NOUN
ffhd-1605	18	9	to	to	PART
ffhd-1605	18	10	reduce	reduce	VERB
ffhd-1605	18	11	tear	tear	ADJ
ffhd-1605	18	12	oxidative	oxidative	ADJ
ffhd-1605	18	13	stress	stress	NOUN
ffhd-1605	18	14	(	(	PUNCT
ffhd-1605	18	15	8	8	NUM
ffhd-1605	18	16	-	-	NUM
ffhd-1605	18	17	ohdg	ohdg	NUM
ffhd-1605	18	18	)	)	PUNCT
ffhd-1605	18	19	and	and	CCONJ
ffhd-1605	18	20	maintain	maintain	VERB
ffhd-1605	18	21	macular	macular	ADJ
ffhd-1605	18	22	pigment	pigment	ADJ
ffhd-1605	18	23	optical	optical	ADJ
ffhd-1605	18	24	density	density	NOUN
ffhd-1605	18	25	(	(	PUNCT
ffhd-1605	18	26	mpod	mpod	NOUN
ffhd-1605	18	27	)	)	PUNCT
ffhd-1605	18	28	,	,	PUNCT
ffhd-1605	18	29	particularly	particularly	ADV
ffhd-1605	18	30	in	in	ADP
ffhd-1605	18	31	individuals	individual	NOUN
ffhd-1605	18	32	with	with	ADP
ffhd-1605	18	33	prolonged	prolonged	ADJ
ffhd-1605	18	34	extended	extended	ADJ
ffhd-1605	18	35	vdt	vdt	PROPN
ffhd-1605	18	36	usage	usage	NOUN
ffhd-1605	18	37	.	.	PUNCT
ffhd-1605	19	1	conclusions	conclusion	NOUN
ffhd-1605	19	2	:	:	PUNCT
ffhd-1605	19	3	these	these	DET
ffhd-1605	19	4	results	result	NOUN
ffhd-1605	19	5	suggest	suggest	VERB
ffhd-1605	19	6	that	that	SCONJ
ffhd-1605	19	7	continuous	continuous	ADJ
ffhd-1605	19	8	ingestion	ingestion	NOUN
ffhd-1605	19	9	of	of	ADP
ffhd-1605	19	10	vitalutein	vitalutein	NOUN
ffhd-1605	19	11	®	®	NOUN
ffhd-1605	19	12	supplements	supplement	NOUN
ffhd-1605	19	13	may	may	AUX
ffhd-1605	19	14	reduce	reduce	VERB
ffhd-1605	19	15	oxidative	oxidative	ADJ
ffhd-1605	19	16	stress	stress	NOUN
ffhd-1605	19	17	and	and	CCONJ
ffhd-1605	19	18	maintain	maintain	VERB
ffhd-1605	19	19	macular	macular	ADJ
ffhd-1605	19	20	pigment	pigment	NOUN
ffhd-1605	19	21	.	.	PUNCT
ffhd-1605	20	1	the	the	DET
ffhd-1605	20	2	product	product	NOUN
ffhd-1605	20	3	has	have	AUX
ffhd-1605	20	4	also	also	ADV
ffhd-1605	20	5	been	be	AUX
ffhd-1605	20	6	proven	prove	VERB
ffhd-1605	20	7	safe	safe	ADJ
ffhd-1605	20	8	in	in	ADP
ffhd-1605	20	9	adult	adult	NOUN
ffhd-1605	20	10	,	,	PUNCT
ffhd-1605	20	11	human	human	ADJ
ffhd-1605	20	12	subjects	subject	NOUN
ffhd-1605	20	13	.	.	PUNCT
ffhd-1605	20	14	  	  	SPACE
ffhd-1605	20	15	keywords	keyword	NOUN
ffhd-1605	20	16	:	:	PUNCT
ffhd-1605	20	17	vitalutein	vitalutein	PROPN
ffhd-1605	20	18	®	®	PROPN
ffhd-1605	20	19	,	,	PUNCT
ffhd-1605	20	20	oxidative	oxidative	ADJ
ffhd-1605	20	21	stress	stress	NOUN
ffhd-1605	20	22	,	,	PUNCT
ffhd-1605	20	23	8	8	NUM
ffhd-1605	20	24	-	-	PUNCT
ffhd-1605	20	25	hydroxy-2	hydroxy-2	NOUN
ffhd-1605	20	26	-	-	PUNCT
ffhd-1605	20	27	deoxyguanosine(8	deoxyguanosine(8	NOUN
ffhd-1605	20	28	-	-	PUNCT
ffhd-1605	20	29	ohdg	ohdg	NOUN
ffhd-1605	20	30	)	)	PUNCT
ffhd-1605	20	31	,	,	PUNCT
ffhd-1605	20	32	visual	visual	ADJ
ffhd-1605	20	33	display	display	NOUN
ffhd-1605	20	34	terminal	terminal	PROPN
ffhd-1605	20	35	(	(	PUNCT
ffhd-1605	20	36	vdt	vdt	PROPN
ffhd-1605	20	37	)	)	PUNCT
ffhd-1605	20	38	,	,	PUNCT
ffhd-1605	20	39	macular	macular	ADJ
ffhd-1605	20	40	pigment	pigment	NOUN
ffhd-1605	20	41	density	density	NOUN
ffhd-1605	20	42	(	(	PUNCT
ffhd-1605	20	43	mpod).(umin	mpod).(umin	NOUN
ffhd-1605	20	44	i	i	NOUN
ffhd-1605	20	45	d	d	NOUN
ffhd-1605	20	46	:	:	PUNCT
ffhd-1605	20	47	umin000014590	umin000014590	PROPN
ffhd-1605	20	48	)	)	PUNCT
ffhd-1605	20	49	downloads	download	VERB
ffhd-1605	21	1	[	[	X
ffhd-1605	21	2	abstract	abstract	X
ffhd-1605	21	3	]	]	X
ffhd-1605	22	1	[	[	X
ffhd-1605	22	2	full	full	ADJ
ffhd-1605	22	3	article	article	NOUN
ffhd-1605	22	4	]	]	PUNCT
ffhd-1605	22	5	published	publish	VERB
ffhd-1605	22	6	2025	2025	NUM
ffhd-1605	22	7	-	-	SYM
ffhd-1605	22	8	05	05	NUM
ffhd-1605	22	9	-	-	PUNCT
ffhd-1605	22	10	14	14	NUM
ffhd-1605	22	11	issue	issue	NOUN
ffhd-1605	22	12	vol	vol	NOUN
ffhd-1605	22	13	.	.	PROPN
ffhd-1605	22	14	15	15	NUM
ffhd-1605	23	1	no	no	NOUN
ffhd-1605	23	2	.	.	NOUN
ffhd-1605	23	3	5	5	NUM
ffhd-1605	23	4	(	(	PUNCT
ffhd-1605	23	5	2025	2025	NUM
ffhd-1605	23	6	):	):	PUNCT
ffhd-1605	23	7	may	may	AUX
ffhd-1605	23	8	2025	2025	NUM
ffhd-1605	23	9	section	section	NOUN
ffhd-1605	23	10	research	research	NOUN
ffhd-1605	23	11	articles	article	NOUN
ffhd-1605	23	12	license	license	VERB
ffhd-1605	23	13	copyright	copyright	NOUN
ffhd-1605	23	14	(	(	PUNCT
ffhd-1605	23	15	c	c	NOUN
ffhd-1605	23	16	)	)	PUNCT
ffhd-1605	23	17	2025	2025	NUM
ffhd-1605	23	18	functional	functional	ADJ
ffhd-1605	23	19	foods	food	NOUN
ffhd-1605	23	20	in	in	ADP
ffhd-1605	23	21	health	health	NOUN
ffhd-1605	23	22	and	and	CCONJ
ffhd-1605	23	23	disease	disease	NOUN
ffhd-1605	23	24	this	this	DET
ffhd-1605	23	25	work	work	NOUN
ffhd-1605	23	26	is	be	AUX
ffhd-1605	23	27	licensed	license	VERB
ffhd-1605	23	28	under	under	ADP
ffhd-1605	23	29	a	a	DET
ffhd-1605	23	30	creative	creative	ADJ
ffhd-1605	23	31	commons	common	NOUN
ffhd-1605	23	32	attribution	attribution	NOUN
ffhd-1605	23	33	-	-	PUNCT
ffhd-1605	23	34	noncommercial	noncommercial	ADJ
ffhd-1605	23	35	4.0	4.0	NUM
ffhd-1605	23	36	international	international	ADJ
ffhd-1605	23	37	license	license	NOUN
ffhd-1605	23	38	.	.	PUNCT
ffhd-1605	24	1	authors	author	NOUN
ffhd-1605	24	2	retain	retain	VERB
ffhd-1605	24	3	the	the	DET
ffhd-1605	24	4	copyright	copyright	NOUN
ffhd-1605	24	5	of	of	ADP
ffhd-1605	24	6	their	their	PRON
ffhd-1605	24	7	articles	article	NOUN
ffhd-1605	24	8	and	and	CCONJ
ffhd-1605	24	9	grant	grant	VERB
ffhd-1605	24	10	the	the	DET
ffhd-1605	24	11	functional	functional	ADJ
ffhd-1605	24	12	food	food	NOUN
ffhd-1605	24	13	center	center	NOUN
ffhd-1605	24	14	(	(	PUNCT
ffhd-1605	24	15	ffc	ffc	NOUN
ffhd-1605	24	16	)	)	PUNCT
ffhd-1605	24	17	and	and	CCONJ
ffhd-1605	24	18	its	its	PRON
ffhd-1605	24	19	journals	journal	NOUN
ffhd-1605	24	20	the	the	DET
ffhd-1605	24	21	right	right	NOUN
ffhd-1605	24	22	of	of	ADP
ffhd-1605	24	23	first	first	ADJ
ffhd-1605	24	24	publication	publication	NOUN
ffhd-1605	24	25	under	under	ADP
ffhd-1605	24	26	the	the	DET
ffhd-1605	24	27	terms	term	NOUN
ffhd-1605	24	28	of	of	ADP
ffhd-1605	24	29	the	the	DET
ffhd-1605	24	30	creative	creative	ADJ
ffhd-1605	24	31	commons	common	NOUN
ffhd-1605	24	32	attribution	attribution	NOUN
ffhd-1605	24	33	4.0	4.0	NUM
ffhd-1605	24	34	international	international	ADJ
ffhd-1605	24	35	license	license	NOUN
ffhd-1605	24	36	.	.	PUNCT
ffhd-1605	25	1	this	this	DET
ffhd-1605	25	2	license	license	NOUN
ffhd-1605	25	3	permits	permit	VERB
ffhd-1605	25	4	unrestricted	unrestricted	ADJ
ffhd-1605	25	5	use	use	NOUN
ffhd-1605	25	6	,	,	PUNCT
ffhd-1605	25	7	distribution	distribution	NOUN
ffhd-1605	25	8	,	,	PUNCT
ffhd-1605	25	9	and	and	CCONJ
ffhd-1605	25	10	reproduction	reproduction	NOUN
ffhd-1605	25	11	in	in	ADP
ffhd-1605	25	12	any	any	DET
ffhd-1605	25	13	medium	medium	NOUN
ffhd-1605	25	14	,	,	PUNCT
ffhd-1605	25	15	including	include	VERB
ffhd-1605	25	16	commercial	commercial	ADJ
ffhd-1605	25	17	use	use	NOUN
ffhd-1605	25	18	,	,	PUNCT
ffhd-1605	25	19	provided	provide	VERB
ffhd-1605	25	20	the	the	DET
ffhd-1605	25	21	original	original	ADJ
ffhd-1605	25	22	author(s	author(s	NOUN
ffhd-1605	25	23	)	)	PUNCT
ffhd-1605	25	24	and	and	CCONJ
ffhd-1605	25	25	source	source	NOUN
ffhd-1605	25	26	are	be	AUX
ffhd-1605	25	27	properly	properly	ADV
ffhd-1605	25	28	credited	credit	VERB
ffhd-1605	25	29	.	.	PUNCT
ffhd-1605	26	1	authors	author	NOUN
ffhd-1605	26	2	may	may	AUX
ffhd-1605	26	3	post	post	VERB
ffhd-1605	26	4	and	and	CCONJ
ffhd-1605	26	5	share	share	VERB
ffhd-1605	26	6	their	their	PRON
ffhd-1605	26	7	published	publish	VERB
ffhd-1605	26	8	work	work	NOUN
ffhd-1605	26	9	freely	freely	ADV
ffhd-1605	26	10	,	,	PUNCT
ffhd-1605	26	11	provided	provide	VERB
ffhd-1605	26	12	that	that	SCONJ
ffhd-1605	26	13	the	the	DET
ffhd-1605	26	14	original	original	ADJ
ffhd-1605	26	15	publication	publication	NOUN
ffhd-1605	26	16	in	in	ADP
ffhd-1605	26	17	this	this	DET
ffhd-1605	26	18	journal	journal	NOUN
ffhd-1605	26	19	is	be	AUX
ffhd-1605	26	20	acknowledged	acknowledge	VERB
ffhd-1605	26	21	.	.	PUNCT
ffhd-1605	27	1	by	by	ADP
ffhd-1605	27	2	submitting	submit	VERB
ffhd-1605	27	3	to	to	ADP
ffhd-1605	27	4	this	this	DET
ffhd-1605	27	5	journal	journal	NOUN
ffhd-1605	27	6	,	,	PUNCT
ffhd-1605	27	7	authors	author	NOUN
ffhd-1605	27	8	confirm	confirm	VERB
ffhd-1605	27	9	that	that	SCONJ
ffhd-1605	27	10	their	their	PRON
ffhd-1605	27	11	manuscripts	manuscript	NOUN
ffhd-1605	27	12	are	be	AUX
ffhd-1605	27	13	original	original	ADJ
ffhd-1605	27	14	,	,	PUNCT
ffhd-1605	27	15	not	not	PART
ffhd-1605	27	16	under	under	ADP
ffhd-1605	27	17	consideration	consideration	NOUN
ffhd-1605	27	18	elsewhere	elsewhere	ADV
ffhd-1605	27	19	,	,	PUNCT
ffhd-1605	27	20	and	and	CCONJ
ffhd-1605	27	21	that	that	SCONJ
ffhd-1605	27	22	they	they	PRON
ffhd-1605	27	23	hold	hold	VERB
ffhd-1605	27	24	the	the	DET
ffhd-1605	27	25	necessary	necessary	ADJ
ffhd-1605	27	26	rights	right	NOUN
ffhd-1605	27	27	to	to	PART
ffhd-1605	27	28	grant	grant	VERB
ffhd-1605	27	29	this	this	DET
ffhd-1605	27	30	license	license	NOUN
ffhd-1605	27	31	.	.	PUNCT
ffhd-1605	28	1	the	the	DET
ffhd-1605	28	2	functional	functional	ADJ
ffhd-1605	28	3	food	food	NOUN
ffhd-1605	28	4	center	center	NOUN
ffhd-1605	28	5	encourages	encourage	VERB
ffhd-1605	28	6	open	open	ADJ
ffhd-1605	28	7	scientific	scientific	ADJ
ffhd-1605	28	8	exchange	exchange	NOUN
ffhd-1605	28	9	and	and	CCONJ
ffhd-1605	28	10	allows	allow	VERB
ffhd-1605	28	11	derivative	derivative	ADJ
ffhd-1605	28	12	and	and	CCONJ
ffhd-1605	28	13	extended	extended	ADJ
ffhd-1605	28	14	works	work	NOUN
ffhd-1605	28	15	,	,	PUNCT
ffhd-1605	28	16	provided	provide	VERB
ffhd-1605	28	17	attribution	attribution	NOUN
ffhd-1605	28	18	to	to	ADP
ffhd-1605	28	19	the	the	DET
ffhd-1605	28	20	original	original	ADJ
ffhd-1605	28	21	publication	publication	NOUN
ffhd-1605	28	22	is	be	AUX
ffhd-1605	28	23	maintained	maintain	VERB
ffhd-1605	28	24	.	.	PUNCT
ffhd-1605	29	1	about	about	ADP
ffhd-1605	29	2	the	the	DET
ffhd-1605	29	3	journal	journal	NOUN
ffhd-1605	29	4	     	     	SPACE
ffhd-1605	29	5	editing	edit	VERB
ffhd-1605	29	6	services	service	NOUN
ffhd-1605	29	7	      	      	SPACE
ffhd-1605	29	8	graphical	graphical	ADJ
ffhd-1605	29	9	abstract	abstract	ADJ
ffhd-1605	29	10	     	     	SPACE
ffhd-1605	29	11	journal	journal	NOUN
ffhd-1605	29	12	insights	insight	NOUN
ffhd-1605	29	13	        	        	SPACE
ffhd-1605	29	14	submissions	submission	NOUN
ffhd-1605	29	15	        	        	SPACE
ffhd-1605	29	16	editorial	editorial	ADJ
ffhd-1605	29	17	team	team	NOUN
ffhd-1605	29	18	       	       	SPACE
ffhd-1605	29	19	privacy	privacy	NOUN
ffhd-1605	29	20	statement	statement	NOUN
ffhd-1605	29	21	        	        	SPACE
ffhd-1605	29	22	contact	contact	NOUN
ffhd-1605	29	23	        	        	SPACE
ffhd-1605	29	24	current	current	ADJ
ffhd-1605	29	25	        	        	SPACE
ffhd-1605	29	26	archives	archive	NOUN
ffhd-1605	29	27	  	  	SPACE
ffhd-1605	29	28	open	open	ADJ
ffhd-1605	29	29	journal	journal	NOUN
ffhd-1605	29	30	systems	system	NOUN
ffhd-1605	29	31	hosting	host	VERB
ffhd-1605	29	32	and	and	CCONJ
ffhd-1605	29	33	support	support	NOUN
ffhd-1605	29	34	by	by	ADP
ffhd-1605	29	35	:	:	PUNCT
ffhd-1605	29	36	openjournalsystems.com	openjournalsystems.com	X